SOUTHLAKE, Texas, May 08, 2026 (GLOBE NEWSWIRE) — American Fusion™ Inc. (OTC: AMFN) (“American Fusion™” or the “Company”), a company focused on fusion energy technologies, reports that fabrication partners in Odessa, Texas have completed the structural frame for the Company’s 5MW Texatron™ pre-production unit, representing an important milestone in the Company’s progression toward integrated system assembly and controlled testing readiness.
The structural frame serves as the primary physical platform for integration of major system components, including wiring infrastructure, control systems, diagnostics, shielding elements, and related security and support features associated with the Texatron™ platform.
The unit is currently undergoing additional integration work and modifications prior to shipment to the Company’s Fort Worth, Texas facility, where American Fusion™ anticipates initiating controlled system testing and instrumentation validation following applicable regulatory review and site readiness preparations.
American Fusion™ has submitted a regulatory application to the Texas Department of State Health Services (“DSHS”) relating to planned testing activities and associated facility infrastructure, including a secure testing environment intended to support controlled fusion system evaluation and diagnostics.
The Company expects the integration and testing phase to occur incrementally, with initial efforts focused on system assembly, diagnostics integration, safety validation, and controlled operational testing prior to any broader performance evaluation activities.
Dr. John Brandenburg, Chief Technology Officer of American Fusion™, stated, “Completion of the pre-production frame is an important engineering milestone because it moves the Texatron platform from prototype development toward integrated system assembly and controlled testing. Our focus now is disciplined integration, instrumentation, regulatory compliance, and data collection so that system performance can ultimately be evaluated in a controlled environment.”
American Fusion™’s transition from prototype development to its first 5MW pre-production Texatron™ unit marks an important inflection point in the Company’s evolution. Having already designed and built nine successive prototypes, American Fusion believes it has demonstrated iterative progress in system design, engineering, and integration.
The move into pre-production signifies a transition from earlier prototype development toward broader system validation and future scalable application. This 5MW unit is not intended as simply another test device, but rather as a commercial-intent system being developed to support controlled testing, diagnostics, performance evaluation, and future deployment considerations. In that sense, it represents an important step toward commercialization, helping bridge the gap between laboratory development and infrastructure-grade energy applications.
In parallel with system integration efforts, the Company is advancing procurement of diagnostic and verification equipment intended to support future testing activities, including instrumentation designed to measure plasma characteristics, electrical output, and other operational performance metrics associated with the Texatron™ architecture.
The Company believes the completion of the structural frame and transition into integrated system assembly represents an important step in advancing the Texatron™ platform toward pre-commercial testing and validation activities.
In support of the Company’s ongoing development, integration, and testing activities, American Fusion™ has engaged Revere Securities LLC (“Revere”) to serve as a non-exclusive finder in connection with a proposed offering of up to $5.0 million (the “Offering”). The Offering is being conducted pursuant to a Securities Purchase Agreement and accompanying Form of Warrant, providing participating institutional and accredited investors with warrant coverage alongside the underlying securities. Revere’s role is limited to introducing prospective investors to the Company; American Fusion™ retains sole responsibility for structuring the Offering, determining final terms, and accepting any subscriptions. Net proceeds are intended to support continued advancement of the Texatron™ platform, including system integration, procurement of diagnostic and verification equipment, regulatory and testing activities, and general working capital.